Abstract -Coronary artery disease (CAD) is the leading cause of death worldwide. Microarray analysis is a practical approach to study gene transcription changes that may reflect signatures that underlie the pathogenesis of CAD. Using gene expression profile data from the Gene Expression Omnibus database, we identified differentially expressed genes that can contribute to the pathology of CAD. Further pathway and network analyses were also implemented to identify pathways and hub genes related to the disease. We observed 466 downregulated and 560 upregulated genes. The ribosome pathway was the most significantly over-represented pathway with differentially expressed genes. Over 35% of the genes in this pathway were downregulated. Hub genes in the network, such as IL7R, FYN, CALM1 ESR1 and PLCG1, may play crucial roles in the pathogenesis of CAD. Our results facilitate the identification of molecular mechanisms that underlie CAD.
INTRODUCTION
As the most common type of heart disease, coronary artery disease (CAD) is the leading cause of death worldwide (Thomas, et al., 1988) . Most patients show no symptoms or signs of CAD for decades during progression of the disease. For most patients, the first onset of symptoms is a sudden heart attack. While considerable efforts have been devoted to the prevention and treatment of CAD, morbidity and mortality remain high. Investigation of the underlying molecular mechanism may accelerate further investigations into new strategies of noninvasive diagnosis and treatment.
Microarray analysis is a practical approach to study gene transcription changes that may reflect signatures underlying CAD pathogenesis. Distinct gene expression patterns in atherosclerotic diseases have been proposed in previous gene expression studies (Hiltunen, et al., 2002; Nanni, et al., 2006; Randi, et al., 2003; Seo, et al., 2004) . Different pathways, such as those involved in the inflammatory process and cell cycle control, have been consistently identified in CAD patients (Cagnin, et al., 2009; Sluimer, et al., 2007) , suggesting that "molecule groups" instead of a single or few proteins should be explored while investigating CAD pathogenesis. Most proteins function through their interaction with other proteins in certain biological pathways. Therefore, analysis from the point of view of pathway and network would provide a better understanding of the mechanisms underlying CAD progression. However, most previous efforts have focused on individual genes.
In this study, with a gene expression data set downloaded from the gene expression omnibus (GEO) database, we identified differentially expressed genes correlated with CAD. Pathways with significantly increased dysregulated genes were also acquired. Protein-protein interaction (PPI) network analysis was also carried out to identify key genes among the differentially expressed genes.
MATERIALS AND METHODS

Microarray data
The transcription profile GSE12288 was downloaded from the GEO database (http://www.ncbi.nlm.nih. gov/geo/). This series represents the gene expression profile for 110 CAD patients and 112 controls. The data set was based on the GPL96 platform: [HG-U133A] Affymetrix Human Genome U133A Array.
Identification of differentially expressed genes
Raw intensity values from raw data files were normalized using Robust Multi-array Analysis (RMA) (Irizarry, et al., 2003) as follows: i) background noise was neutralized by using model-based background correction; ii) expression values were normalized using quantile normalization; iii) the expression value for each probe was generated using an iterative median polishing procedure. The log2-transformed RMA values for each subject were stored for further identification of significantly differentially expressed genes. Correlation analysis with the Benjamini and Hochberg multiple test correction (Benjamini and Hochberg, 1995) was carried out to detect differentially expressed genes. The threshold was set as 0.01. Up-or downregulation of each differentially expressed probe was expressed by fold change. All the above procedures were carried out using R software (v2.15.1) with BioConductor, limma packages (3.12.1) and libraries (Smyth, et al., 2005) .
Pathway enrichment analysis
Selected probes were annotated according to the simple omnibus format in text (SOFT) files. All genes were then annotated based on the KEGG pathways database (http://www.genome.jp/kegg/) (Kanehisa and Goto, 2000) . Enrichment analysis was carried out using the hypergeometric distribution test to identify pathways enriched with differentially expressed genes.
Network analysis
Protein-protein interaction (PPI) is critical for biological processes (Stelzl, et al., 2005) since most proteins function through interactions with other proteins. To illustrate the relationship between the differentially expressed genes, a network was constructed by using Cytoscape (V 2.8.3, http://www. cytoscape.org/) (Shannon, et al., 2003) and the National Center for Biotechnology Information (NCBI) database (http://ftp.ncbi.nlm.nih.gov/gene/GeneR-IF/, 2013-2-25).
RESULTS
We detected 1 026 differentially expressed genes of which 466 genes correlated negatively and 560 genes correlated positively with CAD.
Of all of the well-characterized human genes in the array, 5 298 genes were mapped to various pathways, including 447 differentially expressed genes. The top 10 pathways enriched with dysregulated genes (Table 1) , include two signaling pathways: the calcium signaling pathway (hsa04020) and the adipocytokine signaling pathway (hsa04920). The ribosome pathway (hsa03010) was the most significantly enriched with differentially expressed genes. Among the 119 genes in the ribosome pathway, 45 genes were negatively correlated with CAD. The vascular smooth muscle contraction pathway (hsa04270) and the dilated cardiomyopathy pathway (hsa05414) were also significantly dysregulated. Fig. 1 illustrates the interactions between proteins encoded by differentially expressed genes. The degree of each node is defined as its number of interactions. Nodes with high degrees were considered as hubs. Table 2 represents the top five hub nodes with degrees higher than 10. Most of them were known to be associated with heart disorders. 
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DISCUSSION
The pathophysiology of CAD is highly complex. Here we carried out expression profile analysis to identify differentially expressed genes in CAD patients and healthy controls. Pathway and interaction network analyses were also carried out to explore the underlying mechanism.
Pathway analysis revealed an over-representation of differentially expressed genes in the calciumsignaling pathway (hsa04020). This is consistent with prior knowledge, since Ca 2+ plays important roles in the regulation of contraction and intracellular signaling, which is crucial for the normal function of healthy heart (Cartwright, et al., 2011) . Significant dysregulation of another two pathways, the vascular smooth muscle contraction pathway and the dilated cardiomyopathy pathway, also implicated the interruption of normal heart function in CAD patients. The ribosome pathway was most significantly overrepresented with differentially expressed genes. Over 35% of the genes in this pathway were downregulated. No previous report has proposed the relationship of the ribosome pathway and CAD. However, ribosomal RNA expression was revealed to be highly variable in CAD patients (Fong et al, 2013) . Moreover, in Drosophila melanogaster, cardiomyopathy is associated with ribosomal protein gene haploinsufficiency (Casad, et al., 2011) . Further investigation of this pathway on CAD is warranted.
In the constructed network, IL7R showed the highest degree (Fig. 1, Table 2 ). The protein encoded by the IL7R is a receptor of IL-7, which has been associated with inflammatory processes (Mobini, et al., 2009) . Inflammation has been shown to play crucial pathologic roles in atherosclerosis CAD (Libby,, 2002) . Previous gene expression analysis has also reported the downregulation of IL7R in heart disease patients (Lukk, et al., 2010) . Our investigation further highlights the importance of IL7R in the pathogenesis of CAD.
FYN was a hub gene with the second highest degree (Fig. 1, Table 2 ). The protein encoded by this gene is a membrane-associated tyrosine kinase that has been involved in the control of cell growth. Differential expression of cell cycle genes in CAD patients has been consistently reported (Cagnin, et al., 2009; Ijas, et al., 2007; Mohler, et al., 2008) . The involvement of FYN in the pathogenesis of coronary artery vasculopathy through its activation of the Tcell receptor was observed. Our investigation confirms the relationship between FYN and CAD.
CALM1 encodes a member of the calciumbinding protein family. Our pathway analysis has highlighted the involvement of the calcium-signaling pathway in the pathogenesis of CAD. Previous studies have indicated that a genetic variability of CALM1 was associated with CAD (Luke, et al., 2009; Luke, et al., 2007) . Herein we present evidence for the involvement of this gene in CAD. Another hub gene is ESR1, which encodes the estrogen receptor. Polymorphism of this gene has been associated with CAD in various populations (Almeida and Hutz, 2006; Wei, et al., 2013; Lawlor, et al., 2006) . Our investigation further confirms the involvement of ESR1 in CAD. PLCG1 was also identified as a hub gene. No previous report of the relationship between CAD and PLCG1 has been proposed. Further investigation should be carried out to confirm its implication in the pathogenesis of CAD.
In summary, using gene expression profile data from the GEO database we identified differentially expressed genes that may contribute to the pathology of CAD. Significantly increased representations of dysregulated genes in the ribosome pathway and calcium signaling pathway were identified. Hub genes in the network, such as IL7R, FYN, CALM1 ESR1 and PLCG1, could play crucial roles in the pathogenesis of CAD. Our results facilitate the identification of the molecular mechanism underlying CAD. REFERENCES Almeida, S. and Hutz, M.H. (2006 
